Related Experiment Video
Updated: Dec 14, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Progress towards elimination goals for viral hepatitis
Andrea L Cox1, Manal H El-Sayed2, Jia-Horng Kao3,4
1Department of Medicine, Johns Hopkins University, Baltimore, MD, USA. acox@jhmi.edu.
Insights
Experts question the feasibility of eliminating viral hepatitis by 2030, citing progress gaps. The focus remains on hepatitis B virus and hepatitis C virus elimination strategies for the next decade.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health Policy
Background:
- Viral hepatitis, particularly hepatitis B virus (HBV) and hepatitis C virus (HCV), represents a significant global health burden, comparable to HIV, malaria, and tuberculosis in mortality.
- The World Health Organization set a goal in 2016 for Member States to eliminate viral hepatitis as a public health threat by 2030.
Purpose of the Study:
- To assess the feasibility of achieving viral hepatitis elimination by the 2030 target.
- To identify key areas of progress and critical focus points for viral hepatitis elimination efforts over the next decade and beyond.
Main Methods:
- A viewpoint piece soliciting opinions from leading scientists and clinicians in the viral hepatitis field.
- Analysis of current policy and progress in relation to the 2030 elimination goal.
Main Results:
- While progress has been made, significant policy and implementation gaps persist, raising questions about the attainability of the 2030 deadline.
- Expert opinions highlight the need for sustained focus and strategic interventions to bridge these gaps.
Conclusions:
- Achieving viral hepatitis elimination by 2030 faces considerable challenges, necessitating a re-evaluation of strategies and intensified efforts.
- Continued research, policy development, and clinical advancements are crucial for the long-term goal of viral hepatitis eradication.
Abstract:
The global burden of viral hepatitis is substantial; in terms of mortality, hepatitis B virus and hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top four global infectious diseases. In 2016, the 194 Member States of the World Health Organization committed to eliminating viral hepatitis as a public health threat by 2030, with a particular focus on hepatitis B virus and hepatitis C virus infection. With only 10 years to go until the 2030 deadline is reached, and although much progress has been made towards elimination, there are still some important gaps in terms of policy and progress. In this Viewpoint, we asked a selection of scientists and clinicians working in the viral hepatitis field for their opinions on whether elimination of viral hepatitis by 2030 is feasible, what the key areas of progress are and what the focus for the next 10 years and beyond should be for viral hepatitis elimination.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Retrovirus Life Cycles
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis II: Collaborative Care
Assessment: